The findings from the human TCGA dataset correlates with the genetic and microbiome alterations observed in the OTM mouse model, where there was a significant co-occurrence of alterations in SPTBN1 and SMAD3 or SMAD3 and SMAD4, which were strongly associated with poor overall survival in CRC patients. This evidence concerns the gene SPTBN1 and colorectal carcinoma.